Bos taurus Gene: HDAC1
Summary
InnateDB Gene IDBG-644586.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol HDAC1
Gene Name Histone deacetylase 1
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000012698
Encoded Proteins
Histone deacetylase 1
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary Currently no Entrez Summary Available. You might want to check the Summary Sections of the Orthologs.
Gene Information
Type Protein coding
Genomic Location Chromosome 2:122055992-122087843
Strand Reverse strand
Band
Transcripts
ENSBTAT00000016877 ENSBTAP00000016877
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0000976 transcription regulatory region sequence-specific DNA binding
GO:0000978 RNA polymerase II core promoter proximal region sequence-specific DNA binding
GO:0000980 RNA polymerase II distal enhancer sequence-specific DNA binding
GO:0001047 core promoter binding
GO:0001103 RNA polymerase II repressing transcription factor binding
GO:0001106 RNA polymerase II transcription corepressor activity
GO:0004407 histone deacetylase activity
GO:0005515 protein binding
GO:0016787 hydrolase activity
GO:0019213 deacetylase activity
GO:0019899 enzyme binding
GO:0031078 histone deacetylase activity (H3-K14 specific)
GO:0031492 nucleosomal DNA binding
GO:0032041 NAD-dependent histone deacetylase activity (H3-K14 specific)
GO:0032129 histone deacetylase activity (H3-K9 specific)
GO:0033558 protein deacetylase activity
GO:0033613 activating transcription factor binding
GO:0034739 histone deacetylase activity (H4-K16 specific)
GO:0042826 histone deacetylase binding
GO:0046969 NAD-dependent histone deacetylase activity (H3-K9 specific)
GO:0046970 NAD-dependent histone deacetylase activity (H4-K16 specific)
GO:0097372 NAD-dependent histone deacetylase activity (H3-K18 specific)
Biological Process
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0006351 transcription, DNA-templated
GO:0006355 regulation of transcription, DNA-templated
GO:0006476 protein deacetylation
GO:0008284 positive regulation of cell proliferation
GO:0010870 positive regulation of receptor biosynthetic process
GO:0016568 chromatin modification
GO:0016575 histone deacetylation
GO:0032922 circadian regulation of gene expression
GO:0043044 ATP-dependent chromatin remodeling
GO:0043922 negative regulation by host of viral transcription
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0048511 rhythmic process
GO:0060766 negative regulation of androgen receptor signaling pathway
GO:0070932 histone H3 deacetylation
GO:0070933 histone H4 deacetylation
Cellular Component
GO:0000790 nuclear chromatin
GO:0005634 nucleus
GO:0005654 nucleoplasm
GO:0005829 cytosol
GO:0016580 Sin3 complex
GO:0016581 NuRD complex
GO:0043234 protein complex
Orthologs
No orthologs found for this gene
Pathways
NETPATH
REACTOME
APC truncation mutants have impaired AXIN binding pathway
G0 and Early G1 pathway
Signaling by Wnt pathway
Signaling by WNT in cancer pathway
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant pathway
Generic Transcription Pathway pathway
S33 mutants of beta-catenin aren't phosphorylated pathway
Epigenetic regulation of gene expression pathway
Signaling by NOTCH pathway
Mitotic G1-G1/S phases pathway
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer pathway
Loss of Function of TGFBR1 in Cancer pathway
p75NTR negatively regulates cell cycle via SC1 pathway
Signaling by TGF-beta Receptor Complex pathway
SMAD2/3 MH2 Domain Mutants in Cancer pathway
Factors involved in megakaryocyte development and platelet production pathway
RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription pathway
TCF dependent signaling in response to WNT pathway
Loss of Function of SMAD4 in Cancer pathway
RNA Polymerase I Transcription pathway
misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling pathway
S37 mutants of beta-catenin aren't phosphorylated pathway
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants pathway
deactivation of the beta-catenin transactivating complex pathway
deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling pathway
Loss of Function of TGFBR2 in Cancer pathway
Gene Expression pathway
Hemostasis pathway
Chromatin organization pathway
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex pathway
Cell Cycle, Mitotic pathway
HDACs deacetylate histones pathway
truncations of AMER1 destabilize the destruction complex pathway
AXIN mutants destabilize the destruction complex, activating WNT signaling pathway
NOTCH1 Intracellular Domain Regulates Transcription pathway
XAV939 inhibits tankyrase, stabilizing AXIN pathway
Cell Cycle pathway
Signaling by NOTCH1 in Cancer pathway
TGFBR2 Kinase Domain Mutants in Cancer pathway
Signal Transduction pathway
AXIN missense mutants destabilize the destruction complex pathway
Constitutive Signaling by NOTCH1 PEST Domain Mutants pathway
NoRC negatively regulates rRNA expression pathway
Signaling by TGF-beta Receptor Complex in Cancer pathway
misspliced GSK3beta mutants stabilize beta-catenin pathway
Signaling by NOTCH1 pathway
repression of WNT target genes pathway
TCF7L2 mutants don't bind CTBP pathway
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer pathway
deletions in the AMER1 gene destabilize the destruction complex pathway
RNA Polymerase I Transcription Initiation pathway
Signalling by NGF pathway
AMER1 mutants destabilize the destruction complex pathway
Signaling by NOTCH1 PEST Domain Mutants in Cancer pathway
Negative epigenetic regulation of rRNA expression pathway
RNF mutants show enhanced WNT signaling and proliferation pathway
FBXW7 Mutants and NOTCH1 in Cancer pathway
SMAD4 MH2 Domain Mutants in Cancer pathway
TGFBR2 MSI Frameshift Mutants in Cancer pathway
p75 NTR receptor-mediated signalling pathway
Signaling by NOTCH1 HD Domain Mutants in Cancer pathway
S45 mutants of beta-catenin aren't phosphorylated pathway
Downregulation of SMAD2/3:SMAD4 transcriptional activity pathway
formation of the beta-catenin:TCF transactivating complex pathway
APC truncation mutants are not K63 polyubiquitinated pathway
RNA Polymerase I Promoter Clearance pathway
Loss of Function of SMAD2/3 in Cancer pathway
TGFBR1 LBD Mutants in Cancer pathway
Disease pathway
Degradation of beta-catenin by the destruction complex pathway
Chromatin modifying enzymes pathway
SMAD2/3 Phosphorylation Motif Mutants in Cancer pathway
TGFBR1 KD Mutants in Cancer pathway
T41 mutants of beta-catenin aren't phosphorylated pathway
truncated APC mutants destabilize the destruction complex pathway
KEGG
INOH
PID NCI
Cross-References
SwissProt Q32PJ8
TrEMBL Q6RCM7
UniProt Splice Variant
Entrez Gene 404126
UniGene Bt.16500
RefSeq NM_001037444 XM_005202895
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AY504948 BC108088 BT030718
GenPept AAI08089 AAR98734 ABS45034
RNA Seq Atlas 404126